Dr. Lobelia Samavati, MD

Dr. Samavati practices at DMC Harper University Hospital in Detroit, Michigan, part of Tenet Healthcare.

Dr. Samavati's NPI, 1053358549, was assigned on June 1, 2006. Dr. Samavati holds Michigan license 4301084152.

Dr. Samavati's primary practice is DMC Harper University Hospital, at 3990 John R Street, Detroit, MI 48201 in Wayne County. The practice phone is (313) 745-6211.

Dr. Samavati's primary practice is DMC Harper University Hospital in Detroit, Michigan, part of Tenet Healthcare. Dr. Samavati is also affiliated with DMC Detroit Receiving Hospital. The medical group on file is Wayne Health. Dmand AI also links Dr. Samavati to 1 more hospital and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samavati practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Samavati's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Samavati is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Samavati is licensed in Michigan.

CMS data shows 206 Medicare services from Dr. Samavati across 5 procedure codes in 2024, for 97 Medicare patients. Medicare paid $20,789 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 97 Medicare patients who saw Dr. Samavati in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 54% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samavati's median patient age at 60, with 63% women.

In 2024, Dr. Samavati wrote 464 Medicare Part D claims for 50 patients. 67% of them were for generic drugs. CMS names the drug for 385 of them, across 15 drugs with 11 or more claims each, at $41,799 in total drug cost. In 2023, CMS named 408 claims across 13 drugs.

Dr. Samavati accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 55 papers to Dr. Samavati, published from 2008 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Sarcoidosis, COVID-19 and Sarcoidosis, Pulmonary. Dr. Samavati has published most often in Am J Respir Crit Care Med. Dr. Samavati's most frequent co-authors are Christian P. Bauerfeld, MD, Muhanad Taha, MD and Julie Marie Bourbonnais, MD.

CMS Open Payments shows 5 general payments to Dr. Samavati from 5 drug and device companies from 2016 to 2025. Education make up the largest share, 57% of the total. Genentech, Inc. paid the most, $38.